Clinical Trials Browser

Phase 1 × poly ICLC × Head & Neck × Clear all

NCT02544880 2021-06-15

PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms